Japanese Journal of Infectious Diseases
Online ISSN : 1884-2836
Print ISSN : 1344-6304
ISSN-L : 1344-6304
Short Communication
Development of a Novel Dengue-1 Virus Replicon System Expressing Secretory Gaussia luciferase for Analysis of Viral Replication and Discovery of Antiviral Drugs
Fumihiro KatoTakeshi KobayashiShigeru TajimaTomohiko TakasakiTomoyuki MiuraTatsuhiko IgarashiTakayuki Hishiki
Author information
JOURNAL FREE ACCESS

2014 Volume 67 Issue 3 Pages 209-212

Details
Abstract

Replicon systems have been used for high-throughput screening of anti-dengue virus (anti-DENV) inhibitors and for understanding mechanisms of viral replication. In the present study, we constructed novel DENV-1 replicons encoding Gaussia luciferase that was secreted into the culture medium. Two types of constructs were generated: RNA-based and DNA-based. Each type was translated in an internal ribosome entry site (IRES)-dependent or IRES-independent manner. Among these constructs, the DNA-based replicon employing IRES-dependent translation (DGL2) produced the highest titer. Luciferase levels in the culture medium revealed that the DGL2 replicon was inhibited by ribavirin (a well-known DENV inhibitor) at levels similar to those measured for drug inhibition of multi-round DENV-1 infection. These results indicate that the DNA-based IRES-driven DENV-1 replicon may facilitate studies on viral replication and antiviral compound discovery.

Content from these authors
© Authors
Previous article Next article
feedback
Top